Back to search
Community Acquired Bacterial Pneumonia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Community Acquired Bacterial Pneumonia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Community Acquired Bacterial Pneumonia trials you may qualify forThe goal of this clinical trial is to compare a placebo (a look-alike substance that contains no active drug) with a commonly used antibiotic in children with M…
RECOVERY is a randomised trial of treatments to prevent death in patients hospitalised with pneumonia. The treatments being investigated are: COVID-19: Lopina…
This prospective cohort study aims to characterize the natural progression and outcomes of acute respiratory infections among patients presenting to fever clini…
The goal of this clinical trial is to evaluate the efficacy and safety of faropenem in comparison to co-amoxiclav and clarithromycin in Bangladeshi adults diagn…
The ToolCAP study aims to see if using ultrasound to look at the lungs when children have symptoms of a lung infection will safely allow doctors to improve how…
This is an explorative, mono-center study including prospectively collected patient samples from the University Hospital of Basel. It is to investigate antimicr…
The goal of this prospective randomized study is to improve antibiotic use among hospitalized patients with suspected pneumonia. An alert was built into the ele…
Severe community-acquired pneumonia (CAP) and community-acquired aspiration pneumonia (CAAP) are common reasons for adult emergency department visits and subseq…